Research location
Lenoir
North Carolina, United States
Advertisement
Research activity in Lenoir
North Carolina, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 50 trials and 50 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Lenoir
50 linked trials · page 1 of 1A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityNCT07567001 · 2026-05-11 · 1 site observation
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNCT07064473 · 2025-07-22 · 1 site observation
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityNCT07037459 · 2025-06-25 · 1 site observation
RECRUITING
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartNCT06935370 · 2025-05-20 · 1 site observation
RECRUITING
A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesNCT07553299 · 2026-06-12 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)NCT06864104 · 2025-04-10 · 1 site observation
COMPLETED
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)NCT06383390 · 2024-04-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin MonotherapyNCT03332771 · 2017-12-01 · 1 site observation
COMPLETED
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)NCT03057977 · 2017-03-06 · 1 site observation
COMPLETED
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)NCT03057951 · 2017-03-02 · 1 site observation
COMPLETED
Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection FractionNCT02929329 · 2017-01-06 · 1 site observation
COMPLETED
Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection FractionNCT02874794 · 2016-08-17 · 1 site observation
COMPLETED
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)NCT02727660 · 2016-04-29 · 1 site observation
COMPLETED
Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)NCT02465567 · 2015-06-30 · 1 site observation
COMPLETED
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation
COMPLETED
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk FactorsNCT02019264 · 2014-01-24 · 1 site observation
COMPLETED
Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.NCT01966107 · 2013-10-16 · 1 site observation
COMPLETED
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular EventsNCT01730534 · 2013-04-25 · 1 site observation
COMPLETED
Cardiovascular Inflammation Reduction TrialNCT01594333 · 2013-04-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 DiabetesNCT01719003 · 2012-10-01 · 1 site observation
COMPLETED
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseNCT01609582 · 2012-06-01 · 1 site observation
TERMINATED
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin AloneNCT01555164 · 2012-06-01 · 1 site observation
COMPLETED
Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and DiabetesNCT01496430 · 2012-01-01 · 1 site observation
TERMINATED
Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 HypertensionNCT01508026 · 2012-01-01 · 1 site observation
COMPLETED
Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 HypertensionNCT01415505 · 2011-08-01 · 1 site observation
COMPLETED
ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung CancerNCT01360554 · 2011-06-16 · 1 site observation
COMPLETED
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic HypertensionNCT01218100 · 2010-10-01 · 1 site observation
COMPLETED
A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.NCT01128894 · 2010-05-01 · 1 site observation
COMPLETED
A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung CancerNCT00977561 · 2010-04-01 · 1 site observation
TERMINATED
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone AloneNCT01089790 · 2010-03-01 · 1 site observation
TERMINATED
Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary SyndromeNCT00968708 · 2009-09-01 · 1 site observation
COMPLETED
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With PioglitazoneNCT00970424 · 2009-08-01 · 1 site observation
TERMINATED
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without MetforminNCT00947557 · 2009-07-01 · 1 site observation
TERMINATED
Efficacy and Safety of Albiglutide in Treatment of Type 2 DiabetesNCT00838903 · 2009-02-01 · 1 site observation
COMPLETED
A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 DiabetesNCT00838916 · 2009-02-01 · 1 site observation
COMPLETED
A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 DiabetesNCT00839527 · 2009-02-01 · 1 site observation
COMPLETED
A Study to Evaluate the Effects of LCI699 on Cortisol in Participants With HypertensionNCT00817414 · 2009-01-14 · 1 site observation
COMPLETED
Safety and Efficacy Study of Albiglutide in Type 2 DiabetesNCT00849017 · 2009-01-01 · 1 site observation
COMPLETED
Safety and Efficacy of Albiglutide in Type 2 DiabetesNCT00849056 · 2009-01-01 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant HypertensionNCT00817635 · 2008-12-22 · 1 site observation
COMPLETED
Add-on to Thiazolidinedione (TZD) FailuresNCT00683878 · 2008-07-01 · 1 site observation
COMPLETED
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting GlucoseNCT00673790 · 2008-05-15 · 1 site observation
COMPLETED
The Effect of Nebivolol in Hypertensive Patients With Coronary Artery DiseaseNCT00673075 · 2008-05-01 · 1 site observation
COMPLETED
A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With HypertensionNCT00635232 · 2008-03-01 · 1 site observation
COMPLETED
To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential HypertensionNCT00662896 · 2008-03-01 · 1 site observation
COMPLETED
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast CancerNCT00567190 · 2008-02-12 · 1 site observation
COMPLETED
Soy Protein/Effexor Hormone Therapy for Prostate CancerNCT00354432 · 2007-02-01 · 1 site observation
TERMINATED
A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast CancerNCT00373256 · 2006-11-01 · 1 site observation
COMPLETED
Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917NCT00290940 · 2006-01-01 · 1 site observation
COMPLETED
Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast CancerNCT00096356 · 2004-08-27 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.